NASDAQ New Highs: Huntington Bancshares Incorporated (NASDAQ:HBAN), Myriad Genetics (NASDAQ:MYGN), Brocade Communications (NASDAQ:BRCD), TriQuint Semiconductor (NASDAQ:TQNT)

Huntington Bancshares (NASDAQ:HBAN) stock had its “neutral” rating restated by Compass Point in a research note issued on Thursday, AnalystRatings.Net reports. Huntington Bancshares Incorporated (NASDAQ:HBAN) shares after opening at $10.21 moved to $10.24 on last trade day and at the end of the day closed at $10.13. Company price to sales ratio in past twelve months was calculated as 4.53 and price to cash ratio as 7.71. Huntington Bancshares Incorporated (NASDAQ:HBAN) showed a positive weekly performance of 2.53%.

Medical diagnostic systems and research services providers got a shot in the arm Wednesday as Myriad Genetics (NASDAQ:MYGN) gapped up to its highest level in nearly five years. Myriad Genetics, Inc. (NASDAQ:MYGN) shares advanced 11.47% in last trading session and ended the day on $39.18. MYGN return on equity ratio is recorded as 27.20% and its return on assets is 24.50%. Myriad Genetics, Inc. (NASDAQ:MYGN) yearly performance is 60.90%.

Brocade (NASDAQ:BRCD) on 31 march announced that it will play a strong role expanding the industry mindshare of Software-Defined Networking (SDN) and Network Functions Virtualization (NFV) as an exhibitor at Interop Las Vegas from March 31 to April 4, 2014. Brocade Communications Systems, Inc. (NASDAQ:BRCD) shares moved down -0.46% in last trading session and was closed at $10.79, while trading in range of $10.67 – $10.96. Brocade Communications Systems, Inc. (NASDAQ:BRCD) year to date (YTD) performance is 21.65%.

TriQuint Semiconductor (NASDAQ:TQNT) stock had its “hold” rating reiterated by analysts at Bank of America in a research report issued to clients and investors on Monday, Stock Ratings Network reports. TriQuint Semiconductor (NASDAQ:TQNT) weekly performance is 6.01%. On last trading day company shares ended up $13.75. TriQuint Semiconductor (NASDAQ:TQNT) distance from 50-day simple moving average (SMA50) is 25.63%. Analysts mean target price for the company is $12.24.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *